NCT06122610View on ClinicalTrials.gov

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Neuroendocrine TumorsSomatostatin Receptor-positive Neuroendocrine Tumor
Interventions
DEVICE

Single Photon Emission Computed Tomography/ Computed Tomography (SPECT/CT)

SPECT/CT will be performed after first cycle of Lutathera® treatment

DEVICE

Photon Emission Tomography / CT (PET/CT)

PET/CT will be performed after 64Cu-DOTATATE and Lutathera® treatment

DRUG

64Cu-Dotatate

Standard of care administration of radioactive drug for PET/CT

DRUG

177Lu-Dotatate

Standard of care administration of radioactive drug for PET/CT and SPECT/CT

Trial Locations (1)

53705

RECRUITING

University of Wisconsin - Madison, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER